Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Time-lapse imaging: clearly useful to both laboratory personnel and patient outcomes versus just because we can doesn't mean we should.

Paulson RJ, Reichman DE, Zaninovic N, Goodman LR, Racowsky C.

Fertil Steril. 2018 Apr;109(4):584-591. doi: 10.1016/j.fertnstert.2018.01.042. No abstract available.

PMID:
29653705
2.

Wnt inhibition promotes vascular specification of embryonic cardiac progenitors.

Reichman DE, Park L, Man L, Redmond D, Chao K, Harvey RP, Taketo MM, Rosenwaks Z, James D.

Development. 2018 Jan 8;145(1). pii: dev159905. doi: 10.1242/dev.159905.

3.

Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.

Meyer L, Murphy LA, Gumer A, Reichman DE, Rosenwaks Z, Cholst IN.

Fertil Steril. 2015 Sep;104(3):637-42. doi: 10.1016/j.fertnstert.2015.06.011. Epub 2015 Jul 3.

PMID:
26149355
4.

Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles.

Pereira N, Reichman DE, Goldschlag DE, Lekovich JP, Rosenwaks Z.

J Assist Reprod Genet. 2015 Apr;32(4):527-32. doi: 10.1007/s10815-015-0434-1. Epub 2015 Feb 15.

5.

Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?

Gunnala V, Reichman DE, Meyer L, Davis OK, Rosenwaks Z.

Fertil Steril. 2014 Dec;102(6):1626-32.e1. doi: 10.1016/j.fertnstert.2014.09.015. Epub 2014 Oct 22.

PMID:
25439804
6.

Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.

Reichman DE, Zakarin L, Chao K, Meyer L, Davis OK, Rosenwaks Z.

Fertil Steril. 2014 Jul;102(1):99-102. doi: 10.1016/j.fertnstert.2014.04.010. Epub 2014 May 29.

PMID:
24882557
7.

Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.

Reichman DE, Goldschlag D, Rosenwaks Z.

Fertil Steril. 2014 Apr;101(4):1012-8.e1. doi: 10.1016/j.fertnstert.2013.12.039. Epub 2014 Feb 1.

PMID:
24491452
8.

Fertility in patients with congenital adrenal hyperplasia.

Reichman DE, White PC, New MI, Rosenwaks Z.

Fertil Steril. 2014 Feb;101(2):301-9. doi: 10.1016/j.fertnstert.2013.11.002. Epub 2013 Dec 17. Review.

PMID:
24355046
9.

In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation?

Reichman DE, Gunnala V, Meyer L, Spandorfer S, Schattman G, Davis OK, Rosenwaks Z.

Fertil Steril. 2013 Jul;100(1):94-9. doi: 10.1016/j.fertnstert.2013.02.049. Epub 2013 Apr 20.

PMID:
23615126
10.

Use of antimüllerian hormone: the risks of interpreting ovarian reserve markers in isolation.

Rosenwaks Z, Reichman DE.

Fertil Steril. 2013 Jun;99(7):1850. doi: 10.1016/j.fertnstert.2013.03.036. Epub 2013 Apr 19. No abstract available.

PMID:
23608155
11.

In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval.

Reichman DE, Brauer AA, Goldschlag D, Schattman G, Rosenwaks Z.

Fertil Steril. 2013 Apr;99(5):1408-12. doi: 10.1016/j.fertnstert.2012.11.050. Epub 2013 Jan 8.

PMID:
23312229
12.

Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?

Reichman DE, Chung P, Meyer L, Greenwood E, Davis O, Rosenwaks Z.

Fertil Steril. 2013 Apr;99(5):1277-82. doi: 10.1016/j.fertnstert.2012.11.044. Epub 2013 Jan 3.

PMID:
23290740
13.

Day 3 embryo shape as a morphologic selection parameter in in vitro fertilization.

Kamran SC, Reichman DE, Missmer SA, Correia KF, Karaca N, Romano A, Racowsky C.

J Assist Reprod Genet. 2012 Oct;29(10):1135-9. doi: 10.1007/s10815-012-9842-7. Epub 2012 Aug 14.

14.

Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.

Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE.

Fertil Steril. 2012 Nov;98(5):1225-8. doi: 10.1016/j.fertnstert.2012.07.1056. Epub 2012 Aug 9.

PMID:
22884018
15.

Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?

Reichman DE, Greenwood E, Meyer L, Kligman I, Rosenwaks Z.

Fertil Steril. 2012 Sep;98(3):671-4. doi: 10.1016/j.fertnstert.2012.05.050. Epub 2012 Jul 4.

PMID:
22769734
16.

Developmental potential of embryos from intracytoplasmic sperm injection cycles containing fragmented oocytes.

Kaser DJ, Reichman DE, Ginsburg ES, Politch JA, Racowsky C.

Fertil Steril. 2012 Feb;97(2):338-43. doi: 10.1016/j.fertnstert.2011.11.013. Epub 2011 Dec 7.

PMID:
22153788
17.

Prevention of vulvovaginal sequelae in stevens-johnson syndrome and toxic epidermal necrolysis.

Kaser DJ, Reichman DE, Laufer MR.

Rev Obstet Gynecol. 2011 Summer;4(2):81-5.

18.

Effect of time between human chorionic gonadotropin injection and egg retrieval is age dependent.

Reichman DE, Missmer SA, Berry KF, Ginsburg ES, Racowsky C.

Fertil Steril. 2011 May;95(6):1990-5. doi: 10.1016/j.fertnstert.2011.02.043. Epub 2011 Mar 21.

PMID:
21419407
19.

Extended in vitro maturation of immature oocytes from stimulated cycles: an analysis of fertilization potential, embryo development, and reproductive outcomes.

Reichman DE, Politch J, Ginsburg ES, Racowsky C.

J Assist Reprod Genet. 2010 Jul;27(7):347-56. doi: 10.1007/s10815-010-9416-5. Epub 2010 Apr 28.

20.

Mayer-Rokitansky-Küster-Hauser syndrome: fertility counseling and treatment.

Reichman DE, Laufer MR.

Fertil Steril. 2010 Oct;94(5):1941-3. doi: 10.1016/j.fertnstert.2010.01.036. Epub 2010 Feb 20.

PMID:
20172513

Supplemental Content

Loading ...
Support Center